Seer, Inc. (SEER): Operating Cash Flow
-$44.45M
Year ended 2025-12-31
-$43.38M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$44.45M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$46.11M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$59.06M | n/m | 2025-03-03, From 2023-01-01 |
| 2022-12-31 | -$60.78M | n/m | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | -$46.35M | n/m | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | -$20.83M | n/a | 2022-03-01, From 2020-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Seer, Inc. (SEER) | 2025-12-31 | -$44.45M | n/m |
| Precipio, Inc. (PRPO) | 2025-12-31 | $685.0K | +56.0% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$16.34M | n/m |
| Lifeloc Technologies, Inc (LCTC) | 2025-12-31 | -$499.3K | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$240.11M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$31.06M | n/m |
| Scientific Industries Inc (SCND) | 2025-12-31 | -$8.15M | n/m |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$23.69M | n/m |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $6.73M | +367.3% |
Compare SEER, PRPO, BNGO, LCTC side by side · Screen every company in Laboratory Analytical Instruments ↗